History
A list of downloadable documents created during development.
Review proposal consultation
Background information
Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination
-
Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination information
-
Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination (PDF 199 KB)
-
-
Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination - clarification regarding potential issue with the economic model
-
-
-
-
-
Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination - consultee and commentator comments on the ACD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Lung cancer (non-small-cell, first line) - gefitinib: update to consultees and commentators regarding 3rd appraisal Committee meeting
Lung cancer (non-small-cell, first line) - gefitinib: appraisal consultation document
-
Lung cancer (non-small-cell, first line) - gefitinib: appraisal consultation document
-
Lung cancer (non-small-cell, first line) - gefitinib: appraisal consultation document information
-
Lung cancer (non-small-cell, first line) - gefitinib: evidence considered
-
Lung cancer (non-small-cell, first line) - gefitinib: ACD Pre-meeting briefing (PDF 163 KB)
-
Evidence Review Group report
-
Lung cancer (non-small-cell, first line) - gefitinib: ACD ERG Report (PDF 566 KB)
-
-
-
Non-manufacturer submissions
-
-
-
-
-
Manufacturer submissions
-
-
-
-
-
Expert statements
-
-